Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The sleep apnea implants market size is estimated to be valued at US$ 317.1 million in 2023 and is expected to reach US$ 1,158.1 million by 2033. The adoption of Sleep Apnea Implants is likely to advance at a CAGR of 13.8% during the forecast period.
The rising prevalence of sleep deprivation disorders such as obstructive sleep apnea (OSA), a severe sleep disorder that may increase the risk of fatal accidents or other health-related complications caused due to disturbed sleep has necessitated innovation in Sleep Apnea Implants. Consequences of sleepiness and sleep deprivation are common among people who are shift workers and have headed to several sleep-related disorders. Problems such as OSA, insomnia, jet lag narcolepsy, and sleepwalking are a few of the sleep-related disorders which remain undiagnosed. For instance, according to a study published in the National Institutes of Health journal, around 30% of the adult American population suffers from insomnia and 10% from chronic
A large pool of the population affected by sleep apnea has become more awareness about these disorders and other related ailments. The increasing prevalence of sleep disorders has led to expansion in hospitals and other care centers in various areas, with the establishment of separate divisions dealing with sleep disorders. These sleep centers have increased awareness on tracking sleep patterns for better sleep. Sleep-related awareness is consistently contributing to the increase in the diagnosis rate of sleep disorders. This is expected to drive the sleep apnea implants market.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving the demand for sleep apnea implants. The report tracks the global sales of sleep apnea implants in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the medical device industry in general, and sleep apnea implants in particular.
Attribute | Details |
---|---|
Estimated Market Size (2023) | US$ 317.1 million |
Projected Market Size (2033) | US$ 1,158.1 million |
CAGR through (2023 to 2033) | 13.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
OSA is a progressive disorder affecting more than 200 million people worldwide. According to a study in Lancet, 936 million (95% CI 903–970) adults aged 30–69 years (men and women) were suffering from mild to severe OSA globally. The highest number of affected cases was found in China, followed by the USA, Brazil, and India in 2019.
According to FMI’s analysis, sales of sleep apnea implants have grown at a 12.1% CAGR between 2018 and 2022. Sleep apnea implants have become a potential tool improving airflow and reducing sleep apnea in patients suffering from a sleep disorder. Hypoglossal neurostimulation devices have gained popularity based on their efficacy as compared to other products. FMI expects the global sleep apnea implants market to grow at a 13.8% CAGR through 2033.
Period | Market Size (in US$ million) |
---|---|
2017 | US$ 42.6 million |
2022 | US$ 247.2 million |
2022 | US$ 317.1 million |
2033 | US$ 1,1158.1 million |
Unlocking the Dream: Exploring Lucrative Opportunities in the Sleep Apnea Implants Market
Manufacturers are actively focusing on research and development to innovate advanced devices that meet the customers’ demand and are likely to gain popularity with high revenue share in the competitive market. Advancements in sleep apnea devices include sleep trackers that track sleep patterns based on movement monitoring and also monitor the heart rate. For example, many companies are developing wearables that go on your wrist or finger while sleeping and collect data about the movement and heart rate, while some also track breathing patterns.
Developing countries, such as China and India, have a relatively large population base and the incidence of sleep-related disorders such as insomnia and sleep apnea is comparatively higher than that in other countries. Sleep-related disorders are a serious issue in China and India, which is an opportunity for the leading manufacturers to expand their business in the region and increase their market share. Thus, the rising prevalence of sleep-related disorders is expected to offer robust opportunities for the manufacturers in the sleep apnea implants market.
Nurturing a Silent Revolution: Government and Non-governmental Initiatives Powering Sleep Apnea Implants Sales
Numerous government and non-government organizations such as Circadian Sleep Disorders Network and the American Sleep Apnea Association (ASAA) conduct sleep awareness programs regarding the importance of ample sleep and usage of sleep apnea devices. These organizations are launching several awareness programs to educate people about sleep hygiene and technological aid to get better sleep. For example, Sleep Awareness Week was celebrated by the National Sleep Foundation with the theme “Begin with Sleep Moreover” in March 2018.
Various organizations are improving their services to offer greater customer satisfaction. For instance, the American Sleep Association is an organization dedicated to improving public health by increasing awareness about the importance of sleep and the dangers of sleep disorders. Government approval is expected to propel the sleep apnea implants market growth.
Due to an increase in the need for assessment of OSA breathe in peripheral artery disease and limb ischemia, many manufacturers seek 510(k) Premarket Notification from the U.S. Food and Drug Administration (“FDA”) which demonstrates the device to be safe and effective, equivalent to a legally marketed device. For example, in May 2019, Siesta Medical, Inc. (Private) announced FDA clearance for expanded indications for its Encore™ Tongue Suspension System for the treatment of obstructive sleep apnea.
Implementing government guidelines for prescription reformation attracts end-users, which is expected to boost the demand for sleep apnea implants. For instance, in February 2021, the FDA authorized the marketing of eXciteOSA® (Signifier Medical Technologies), a new prescription intended to reduce sleep snoring and OSA in patients 18 years and older.
Unmasking the Barriers: Unlocking the Potential of Sleep Apnea Implants amidst Sales Impediments
Continuous positive airway pressure (CPAP) is the most popular technology adopted for the assessment of sleep deprivation-associated disorders. CPAP devices come in different price ranges depending upon the number of features. The high upfront cost can have a negative impact on the end users’ decision to purchase sleep apnea implants.
Some of the most effective sleep disorder treatments are quite expensive. As a general rule, the surgery associated with the placement of the Inspire hypoglossal nerve stimulator may cost $30,000 to $40,000 (with the device itself costing about $20,000 of this total). Thus, high cost of the technology as well as the treatment is the major factor expected to hamper the market growth.
Sleep Apnea Implants Market:
Attributes | Sleep Apnea Implants Market |
---|---|
CAGR (2023 to 2033) | 13.8% |
Market Value (2033) | US$ 1,158.1 million |
Opportunity | An emerging opportunity in the sleep apnea implants market is the integration of artificial intelligence and machine learning algorithms for personalized and real-time therapy adjustments. |
Key Trends | Key trend emerging in the sleep apnea implants market include advancements in neurostimulation technology. |
Sleep Apnea Devices Market:
Attributes | Sleep Apnea Devices Market |
---|---|
CAGR (2023 to 2033) | 9.5% |
Market Value (2033) | US$ 20.4 billion |
Opportunity | An emerging opportunity in the sleep apnea devices market is the integration of artificial intelligence and machine learning algorithms to enhance personalized treatment and improve patient outcomes. |
Key Trends | Key trend emerging in the sleep apnea devices market is the integration of advanced sensing technologies for precise monitoring and personalized treatment. |
Home-Sleep-Apnea-Testing Market:
Attributes | Home-Sleep-Apnea-Testing Market |
---|---|
CAGR (2023 to 2033) | 14.9% |
Market Value (2033) | US$ 4 billion |
Opportunity | An emerging opportunity in the home-sleep-apnea-testing market is the increasing demand for user-friendly and convenient portable sleep apnea testing devices. |
Key Trends | Home sleep apnea testing (HSAT) offers convenience and comfort for patients, leading to a growing preference for home-based diagnostic options. |
Unleashing the Potential: Unraveling the Vast Opportunity Landscape in the United States Sleep Apnea Implants Market
The healthcare system of the United States is highly renowned for its well-developed infrastructure and high expenditure. The care regimes in the care centers and hospitals are covered by regulatory rules and insurance policies. The massive hospital bills incurred other than Medicare escalate the market in the country.
The United States government and regulatory bodies are actively adopting several cost-containment plans to reduce their healthcare burden. The shift from a volume-based to a value-based system is majorly driven by the various measures undertaken by providers, governments, biotechnology companies, and insurance payers. Some of the measures are outcome-based profits, pricing, risk-sharing, competitive tendering, and price control.
A value-based healthcare system will not only provide improved outcomes through integrated care pathways, but also levy pricing pressure on medical device companies, and this is likely to impact investments in the R&D of advanced medical treatment technologies. In June 2020, the IDE trial was approved by FDA, with the first United States and international implants.
Due to the high prevalence of sleep disorders in the United States, the government as well as non-government organizations are conducting campaigns to raise general awareness among people suffering from these diseases. This is likely to support the overall market growth in the country.
Breaking New Ground: Unleashing Innovation's Power for Success in the German Medical Device Market
The Federal Statistical Office has reported that healthcare spending in Germany rose by 4% in 2018 from 2017. In 2018, the country’s healthcare spending accounted for 11.7% of the GDP. The health expenditure was expected to surge to 407.4 billion euros by 2019, presenting a lucrative landscape for the expansion of sleep apnea implants sales.
The presence of domestic players such as Carl Martin GmbH is supporting the expansion in Germany. The company has been investing significantly in expansion efforts.
Since 2009, health insurance has been made mandatory for all citizens of the country. According to NCBI, a total of 70 million people, which roughly covers 85% of the population, are covered by statutory health insurance. Another 11% of the population of Germany is covered by substitutive private health insurance. Conducive reimbursement policies and regulatory scenario are presenting attractive growth opportunities.
Unleashing the Dragon's Purchasing Power: China's Soaring Disposable Income Set to Fuel Market Surge
Increasing disposable income can have a significant impact on the development of the economy in emerging countries, which results in the affordability of proper healthcare treatments. China’s per capita disposable income reached about 4,961 U.S. dollars in 2020, more than double that in 2010.
The potential for high healthcare insurance and rising disposable income will contribute to increasing affordability of healthcare services and also accessibility to expensive equipment for the treatment of diseases. The market in China is expected to witness significant growth at a CAGR of around 15.7% during the forecast period.
Navigating the Slumbering Challenges: Unveiling the Restraints Encountered by GCC Countries in the Sleep Apnea Implants Domain
Lack of awareness about complete sleep and related disorders and lack of treatment or low adoption of therapy due to high cost raises the prevalence of sleep disorders in GCC Countries. Due to limited campaigning and assessment of the undiagnosed disorders, there seems to occur less usage of these devices in hospitals in GCC Countries.
Poor healthcare facilities in some countries restrain the growth of the sleep apnea implants market. Due to financial burdens, governments fail to provide proper treatment and are unable to facilitate campaigns to create awareness among the population, which may impact the usage of advanced devices. The market in GCC Countries is expected to witness sluggish growth during the forecast period.
OSA Dominance Unveiled: Unraveling the Sleep Apnea Implants Market Share Phenomenon
The OSA segment will continue to grow and dominate the market during the forecast period. According to FMI, the segment is expected to hold 91.34% of the market share, in terms of indication, by the end of 2033.
OSA is the most common sleep-related breathing disorder and is characterized by recurrent episodes of complete or partial obstruction of the upper airway leading to reduced or absent breathing during sleep. The rising prevalence of OSA across the global population leads to a spike in share for the OSA segment in the market.
Unlocking a Breath of Relief: The Phenomenon behind Hypoglossal Neurostimulation Devices' Reign in the Sleep Apnea Implants Market
Hypoglossal Neurostimulation Devices hold the highest share in the sleep apnea implants market. Hypoglossal neurostimulation devices are meant to treat pharyngeal tone and stimulates genioglossus protrusion to the open airway by the tongue during sleep.
These devices reduce the risk for severe dysphagia and throat pain that witnessed by a surge in the demand for the device in the market.
Pioneering Partnerships: Unveiling the Powerful Influence of Hospitals on Sleep Apnea Implants Sales
The hospital segment is expected to dominate the sleep apnea implants market through the forecast period. Higher footfall of sleep apnea patients in hospitals will seal their position as the dominant end user.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In the ever-evolving realm of sleep apnea implants, a fierce competition unfolds as key players vie for supremacy. Industry frontrunners deploy innovative technologies, cutting-edge research, and strategic partnerships to gain a decisive edge. Titans clash as they strive to capture significant market shares, revolutionize treatment outcomes, and improve patient experiences.
Established giants showcase their prowess, while nimble startups disrupt the status quo with disruptive solutions. As the battle intensifies, companies tirelessly invest in R&D, focusing on implant efficacy, patient comfort, and remote monitoring capabilities. In this dynamic arena, the competitive landscape continuously evolves, forging new alliances, sparking acquisitions, and fueling innovation. Amidst this fierce contest, it is the sleep apnea sufferers who stand to benefit the most, as a relentless pursuit of excellence drives the industry towards a brighter future.
Strategies for Sleep Apnea Implants Manufacturers to Expand in the Market
Product Portfolio:
Report Attribute | Details |
---|---|
Market Value in 2023 | US$ 317.1 million |
Market Value in 2033 | US$ 1,158.1 million |
Growth Rate | CAGR of 13.8% from 2023 to 2033 |
Base Year for Estimation | 2022 |
Historical Data | 2018 to 2022 |
Forecast Period | 2023 to 2033 |
Quantitative Units | Revenue in US$ billion and CAGR from 2023 to 2033 |
Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
Customization & Pricing | Available upon Request |
The market is set to amount to US$ 1,158.1 million by 2033.
The growth potential of the market is 13.8% through 2033.
Manufacturers are developing advanced devices to popularize their brands and gain a larger share.
American Sleep Apnea Association (ASAA) and Circadian Sleep Disorders Network are contributing to the product demand.
Developments in neurostimulation technology have a prominent influence on the market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033 5.3.1. Phrenic Nerve Stimulator 5.3.2. Hypoglossal Neurostimulation Devices 5.3.3. Bone Screw Implant System 5.3.4. Flexible Tongue Retractor System 5.3.5. Palatal Implants/Pillar Procedure 5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2023 to 2033 6.3.1. Central Sleep Apnea 6.3.2. Obstructive Sleep Apnea (OSA) 6.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 7.3.1. Hospitals 7.3.2. Ambulatory Surgical Centers 7.3.3. Office Based Clinics 7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. South Asia 8.3.5. East Asia 8.3.6. Oceania 8.3.7. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By Indication 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Indication 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By Indication 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Indication 10.3.4. By End User 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. U.K. 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Product 11.2.3. By Indication 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Indication 11.3.4. By End User 11.4. Key Takeaways 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Malaysia 12.2.1.3. Singapore 12.2.1.4. Thailand 12.2.1.5. Rest of South Asia 12.2.2. By Product 12.2.3. By Indication 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Indication 12.3.4. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Product 13.2.3. By Indication 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Indication 13.3.4. By End User 13.4. Key Takeaways 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Product 14.2.3. By Indication 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Indication 14.3.4. By End User 14.4. Key Takeaways 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product 15.2.3. By Indication 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Indication 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. U.S. 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product 16.1.2.2. By Indication 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product 16.2.2.2. By Indication 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product 16.3.2.2. By Indication 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product 16.4.2.2. By Indication 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product 16.5.2.2. By Indication 16.5.2.3. By End User 16.6. U.K. 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product 16.6.2.2. By Indication 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product 16.7.2.2. By Indication 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product 16.8.2.2. By Indication 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product 16.9.2.2. By Indication 16.9.2.3. By End User 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product 16.10.2.2. By Indication 16.10.2.3. By End User 16.11. Malaysia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product 16.11.2.2. By Indication 16.11.2.3. By End User 16.12. Singapore 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product 16.12.2.2. By Indication 16.12.2.3. By End User 16.13. Thailand 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product 16.13.2.2. By Indication 16.13.2.3. By End User 16.14. China 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product 16.14.2.2. By Indication 16.14.2.3. By End User 16.15. Japan 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product 16.15.2.2. By Indication 16.15.2.3. By End User 16.16. South Korea 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product 16.16.2.2. By Indication 16.16.2.3. By End User 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product 16.17.2.2. By Indication 16.17.2.3. By End User 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product 16.18.2.2. By Indication 16.18.2.3. By End User 16.19. GCC Countries 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product 16.19.2.2. By Indication 16.19.2.3. By End User 16.20. South Africa 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product 16.20.2.2. By Indication 16.20.2.3. By End User 16.21. Israel 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Product 16.21.2.2. By Indication 16.21.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product 17.3.3. By Indication 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Inspire Medical Systems 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Respicardia, Inc. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Medtronic Plc 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. LinguaFlex LLC 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Siesta Medical, Inc. 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Avery biomedical 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Nyxoah SA 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. LivaNova/ImThera 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. ASAHI KASEI CORP 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. SomnoMed 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 10: Latin America Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 14: Europe Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 15: Europe Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 16: Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 17: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 18: South Asia Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 19: South Asia Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 20: South Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 21: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: East Asia Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 23: East Asia Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 24: East Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 25: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 26: Oceania Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 27: Oceania Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 28: Oceania Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 29: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 30: MEA Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 31: MEA Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 32: MEA Market Value (US$ Million) Forecast by End User, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Product, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Indication, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by End User, 2023 to 2033 Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 8: Global Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 9: Global Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 10: Global Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 11: Global Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 12: Global Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 13: Global Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 14: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 17: Global Market Attractiveness by Product, 2023 to 2033 Figure 18: Global Market Attractiveness by Indication, 2023 to 2033 Figure 19: Global Market Attractiveness by End User, 2023 to 2033 Figure 20: Global Market Attractiveness by Region, 2023 to 2033 Figure 21: North America Market Value (US$ Million) by Product, 2023 to 2033 Figure 22: North America Market Value (US$ Million) by Indication, 2023 to 2033 Figure 23: North America Market Value (US$ Million) by End User, 2023 to 2033 Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 28: North America Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 29: North America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 30: North America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 37: North America Market Attractiveness by Product, 2023 to 2033 Figure 38: North America Market Attractiveness by Indication, 2023 to 2033 Figure 39: North America Market Attractiveness by End User, 2023 to 2033 Figure 40: North America Market Attractiveness by Country, 2023 to 2033 Figure 41: Latin America Market Value (US$ Million) by Product, 2023 to 2033 Figure 42: Latin America Market Value (US$ Million) by Indication, 2023 to 2033 Figure 43: Latin America Market Value (US$ Million) by End User, 2023 to 2033 Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 48: Latin America Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 52: Latin America Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 54: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 57: Latin America Market Attractiveness by Product, 2023 to 2033 Figure 58: Latin America Market Attractiveness by Indication, 2023 to 2033 Figure 59: Latin America Market Attractiveness by End User, 2023 to 2033 Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 61: Europe Market Value (US$ Million) by Product, 2023 to 2033 Figure 62: Europe Market Value (US$ Million) by Indication, 2023 to 2033 Figure 63: Europe Market Value (US$ Million) by End User, 2023 to 2033 Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 68: Europe Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 69: Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 70: Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 71: Europe Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 72: Europe Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 73: Europe Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 74: Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 75: Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 76: Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 77: Europe Market Attractiveness by Product, 2023 to 2033 Figure 78: Europe Market Attractiveness by Indication, 2023 to 2033 Figure 79: Europe Market Attractiveness by End User, 2023 to 2033 Figure 80: Europe Market Attractiveness by Country, 2023 to 2033 Figure 81: South Asia Market Value (US$ Million) by Product, 2023 to 2033 Figure 82: South Asia Market Value (US$ Million) by Indication, 2023 to 2033 Figure 83: South Asia Market Value (US$ Million) by End User, 2023 to 2033 Figure 84: South Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 85: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 88: South Asia Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 89: South Asia Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 91: South Asia Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 92: South Asia Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 94: South Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 95: South Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 96: South Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 97: South Asia Market Attractiveness by Product, 2023 to 2033 Figure 98: South Asia Market Attractiveness by Indication, 2023 to 2033 Figure 99: South Asia Market Attractiveness by End User, 2023 to 2033 Figure 100: South Asia Market Attractiveness by Country, 2023 to 2033 Figure 101: East Asia Market Value (US$ Million) by Product, 2023 to 2033 Figure 102: East Asia Market Value (US$ Million) by Indication, 2023 to 2033 Figure 103: East Asia Market Value (US$ Million) by End User, 2023 to 2033 Figure 104: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 105: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 108: East Asia Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 109: East Asia Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 111: East Asia Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 112: East Asia Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 114: East Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 115: East Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 116: East Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 117: East Asia Market Attractiveness by Product, 2023 to 2033 Figure 118: East Asia Market Attractiveness by Indication, 2023 to 2033 Figure 119: East Asia Market Attractiveness by End User, 2023 to 2033 Figure 120: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 121: Oceania Market Value (US$ Million) by Product, 2023 to 2033 Figure 122: Oceania Market Value (US$ Million) by Indication, 2023 to 2033 Figure 123: Oceania Market Value (US$ Million) by End User, 2023 to 2033 Figure 124: Oceania Market Value (US$ Million) by Country, 2023 to 2033 Figure 125: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 128: Oceania Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 129: Oceania Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 131: Oceania Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 132: Oceania Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 134: Oceania Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 135: Oceania Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 137: Oceania Market Attractiveness by Product, 2023 to 2033 Figure 138: Oceania Market Attractiveness by Indication, 2023 to 2033 Figure 139: Oceania Market Attractiveness by End User, 2023 to 2033 Figure 140: Oceania Market Attractiveness by Country, 2023 to 2033 Figure 141: MEA Market Value (US$ Million) by Product, 2023 to 2033 Figure 142: MEA Market Value (US$ Million) by Indication, 2023 to 2033 Figure 143: MEA Market Value (US$ Million) by End User, 2023 to 2033 Figure 144: MEA Market Value (US$ Million) by Country, 2023 to 2033 Figure 145: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 148: MEA Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 149: MEA Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 150: MEA Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 151: MEA Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 152: MEA Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 153: MEA Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 154: MEA Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 155: MEA Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 156: MEA Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 157: MEA Market Attractiveness by Product, 2023 to 2033 Figure 158: MEA Market Attractiveness by Indication, 2023 to 2033 Figure 159: MEA Market Attractiveness by End User, 2023 to 2033 Figure 160: MEA Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports